Stock Screener
Stock Research
Delisted Stocks
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

QIAGEN Debt to Equity Ratio 2010-2023 | QGEN

Current and historical debt to equity ratio values for QIAGEN (QGEN) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. QIAGEN debt/equity for the three months ending June 30, 2023 was 0.38.
  
QIAGEN Debt/Equity Ratio Historical Data
Date Long Term Debt Shareholder's Equity Debt to Equity Ratio
2023-06-30 $2.72B $3.62B 0.75
2023-03-31 $2.72B $3.56B 0.76
2022-12-31 $2.82B $3.47B 0.81
2022-09-30 $3.19B $3.33B 0.96
2022-06-30 $2.87B $3.28B 0.88
2022-03-31 $2.94B $3.24B 0.91
2021-12-31 $3.05B $3.10B 0.99
2021-09-30 $3.03B $3.01B 1.01
2021-06-30 $2.93B $2.98B 0.98
2021-03-31 $2.91B $2.85B 1.02
2020-12-31 $3.07B $2.80B 1.10
2020-09-30 $3.06B $2.71B 1.13
2020-06-30 $2.67B $2.62B 1.02
2020-03-31 $2.69B $2.49B 1.08
2019-12-31 $2.70B $2.54B 1.06
2019-09-30 $2.68B $2.47B 1.08
2019-06-30 $2.75B $2.63B 1.05
2019-03-31 $2.81B $2.61B 1.08
2018-12-31 $3.11B $2.64B 1.18
2018-09-30 $2.77B $2.53B 1.10
2018-06-30 $2.79B $2.52B 1.10
2018-03-31 $2.53B $2.58B 0.98
2017-12-31 $2.50B $2.54B 0.98
2017-09-30 $2.53B $2.57B 0.99
2017-06-30 $2.05B $2.51B 0.82
2017-03-31 $1.64B $2.43B 0.67
2016-12-31 $1.70B $2.61B 0.65
2016-09-30 $1.66B $2.67B 0.62
2016-06-30 $1.49B $2.63B 0.57
2016-03-31 $1.50B $2.63B 0.57
2015-12-31 $1.61B $2.57B 0.63
2015-09-30 $1.64B $2.52B 0.65
2015-06-30 $1.59B $2.54B 0.63
2015-03-31 $1.69B $2.48B 0.68
2014-12-31 $1.80B $2.66B 0.68
2014-09-30 $1.75B $2.71B 0.64
2014-06-30 $1.81B $2.76B 0.66
2014-03-31 $1.75B $2.73B 0.64
2013-12-31 $1.37B $2.72B 0.50
2013-09-30 $1.38B $2.68B 0.52
2013-06-30 $1.38B $2.60B 0.53
2013-03-31 $1.34B $2.69B 0.50
2012-12-31 $1.36B $2.72B 0.50
2012-09-30 $1.25B $2.71B 0.46
2012-06-30 $1.24B $2.64B 0.47
2012-03-31 $1.16B $2.64B 0.44
2011-12-31 $1.17B $2.56B 0.46
2011-09-30 $1.36B $2.59B 0.53
2011-06-30 $1.40B $2.59B 0.54
2011-03-31 $1.42B $2.54B 0.56
2010-12-31 $1.44B $2.48B 0.58
2010-09-30 $1.46B $2.43B 0.60
2010-06-30 $1.43B $2.34B 0.61
2010-03-31 $1.47B $2.31B 0.64
2009-12-31 $1.51B $2.29B 0.66
2009-09-30 $1.53B $2.23B 0.69
2009-06-30 $1.44B $1.54B 0.94
2009-03-31 $1.37B $1.46B 0.94
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $9.031B $2.142B
QIAGEN N.V. is one of the world's leading providers of technologies and products for the separation, purification and handling of nucleic acids DNA/RNA. The company provides innovative technologies and products for pre-analytical sample preparation and molecular diagnostics solutions. It has developed a comprehensive portfolio of proprietary, consumable products, and automated solutions for sample collection. Qiagen has subsidiaries several other countries with good sales potential. Segment Details Consumables: These are typically sample preparation or test kits that contain all the necessary reagents and buffers, and a manual including protocols and relevant background information. Automated Instruments: These automate the use of Sample & Assay Technologies into efficient solutions for a broad range of laboratory needs. Customer Classes: QIAGEN focuses on 4 principal segments or customer classes for sample and assay technologies:? Molecular Diagnostics, Applied Testing, Pharma and Academia.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $143.910B 15.14
Bristol Myers Squibb (BMY) United States $122.296B 7.69
Gilead Sciences (GILD) United States $94.111B 12.03
Vertex Pharmaceuticals (VRTX) United States $90.769B 26.74
Regeneron Pharmaceuticals (REGN) United States $90.365B 21.81
CSL (CSLLY) Australia $78.962B 0.00
GSK (GSK) United Kingdom $76.331B 10.36
Seagen (SGEN) United States $40.573B 0.00
Biogen (BIIB) United States $37.372B 15.89
Moderna (MRNA) United States $37.344B 36.21
Argenex SE (ARGX) Netherlands $28.305B 0.00
Horizon Therapeutics Public (HZNP) Ireland $26.504B 25.78
BioNTech SE (BNTX) Germany $24.547B 5.71
Genmab (GMAB) Denmark $24.131B 36.53
Alnylam Pharmaceuticals (ALNY) United States $21.881B 0.00
Illumina (ILMN) United States $20.406B 146.49
BeiGene (BGNE) Cayman Islands $17.971B 0.00
BioMarin Pharmaceutical (BMRN) United States $16.571B 88.06
Incyte (INCY) United States $13.284B 32.39
Exact Sciences (EXAS) United States $12.002B 0.00
Bio-Rad Laboratories (BIO.B) United States $10.868B 30.51
Bio-Techne Corp (TECH) United States $10.684B 38.09
Legend Biotech (LEGN) United States $10.624B 0.00
Sarepta Therapeutics (SRPT) United States $10.508B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $10.482B 0.00
Roivant Sciences (ROIV) United Kingdom $9.577B 0.00
Repligen (RGEN) United States $8.847B 60.56
Exelixis (EXEL) United States $6.925B 42.65
Reata Pharmaceuticals (RETA) United States $6.576B 0.00
Sino Biopharmaceutical (SBMFF) Hong Kong, SAR China $6.397B 0.00
Karuna Therapeutics (KRTX) United States $6.301B 0.00
Swedish Orphan Biovitrum (BIOVF) Sweden $5.888B 19.00
Ascendis Pharma (ASND) Denmark $5.384B 0.00
Immunovant (IMVT) United States $5.222B 0.00
Intra-Cellular Therapies (ITCI) United States $5.156B 0.00
Apellis Pharmaceuticals (APLS) United States $5.084B 0.00
Halozyme Therapeutics (HALO) United States $5.075B 17.10
Vaxcyte (PCVX) United States $4.840B 0.00
Alkermes (ALKS) Ireland $4.825B 241.42
ACADIA Pharmaceuticals (ACAD) United States $3.869B 0.00
Insmed (INSM) United States $3.706B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $3.662B 0.00
Ginkgo Bioworks Holdings (DNA) United States $3.631B 0.00
Amicus Therapeutics (FOLD) United States $3.514B 0.00
MoonLake Immunotherapeutics (MLTX) Switzerland $3.466B 0.00
Axsome Therapeutics (AXSM) United States $3.419B 0.00
Krystal Biotech (KRYS) United States $3.229B 0.00
Guardant Health (GH) United States $3.036B 0.00
Blueprint Medicines (BPMC) United States $3.029B 0.00
Denali Therapeutics (DNLI) United States $2.939B 0.00
Cytokinetics (CYTK) United States $2.880B 0.00
Intellia Therapeutics (NTLA) United States $2.863B 0.00
HUTCHMED (China) (HCM) Hong Kong, SAR China $2.824B 0.00
Ultragenyx Pharmaceutical (RARE) United States $2.675B 0.00
Prothena (PRTA) Ireland $2.547B 0.00
Akero Therapeutics (AKRO) United States $2.537B 0.00
Fortrea Holdings (FTRE) United States $2.517B 0.00
Immunocore Holdings (IMCR) United Kingdom $2.486B 0.00
Zai Lab (ZLAB) China $2.463B 0.00
Nuvalent (NUVL) United States $2.400B 0.00
Mirati Therapeutics (MRTX) United States $2.382B 0.00
Zealand Pharma (ZLDPF) Denmark $2.278B 0.00
Galapagos (GLPG) Belgium $2.270B 0.00
Xenon Pharmaceuticals (XENE) Canada $2.247B 0.00
Certara (CERT) United States $2.221B 36.58
Harmony Biosciences Holdings (HRMY) United States $2.040B 11.33
Ventyx Biosciences (VTYX) United States $1.998B 0.00
Beam Therapeutics (BEAM) United States $1.869B 0.00
Dynavax Technologies (DVAX) United States $1.834B 19.78
Bavarian Nordic (BVNRY) Denmark $1.693B 10.20
Arcellx (ACLX) United States $1.676B 0.00
Rocket Pharmaceuticals (RCKT) United States $1.656B 0.00
CureVac (CVAC) Germany $1.647B 0.00
Vericel (VCEL) United States $1.596B 0.00
NeoGenomics (NEO) United States $1.570B 0.00
IDEAYA Biosciences (IDYA) United States $1.521B 0.00
SpringWorks Therapeutics (SWTX) United States $1.489B 0.00
Zentalis Pharmaceuticals (ZNTL) United States $1.447B 0.00
Arcus Biosciences (RCUS) United States $1.430B 0.00
AbCellera Biologics (ABCL) Canada $1.360B 0.00
Rhythm Pharmaceuticals (RYTM) United States $1.353B 0.00
Myriad Genetics (MYGN) United States $1.309B 0.00
Structure Therapeutics (GPCR) United States $1.295B 0.00
Celldex Therapeutics (CLDX) United States $1.253B 0.00
Vir Biotechnology (VIR) United States $1.242B 0.00
Biohaven (BHVN) United States $1.206B 0.00
Viking Therapeutics (VKTX) United States $1.193B 0.00
ANI Pharmaceuticals (ANIP) United States $1.189B 19.02
89BIO (ETNB) United States $1.184B 0.00
Kiniksa Pharmaceuticals (KNSA) Bermuda $1.170B 31.47
Mirum Pharmaceuticals (MIRM) United States $1.163B 0.00
Twist Bioscience (TWST) United States $1.140B 0.00
Merus (MRUS) Netherlands $1.135B 0.00
Geron (GERN) United States $1.130B 0.00
Tango Therapeutics (TNGX) United States $1.126B 0.00
Arvinas (ARVN) United States $1.116B 0.00
Disc Medicine (IRON) United States $1.108B 0.00
Iovance Biotherapeutics (IOVA) United States $1.100B 0.00
Syndax Pharmaceuticals (SNDX) United States $1.095B 0.00
Revance Therapeutics (RVNC) United States $1.092B 0.00
Day One Biopharmaceuticals (DAWN) United States $1.086B 0.00
MannKind (MNKD) United States $1.081B 0.00
Northwest Biotherapeutics (NWBO) United States $1.074B 0.00
Apogee Therapeutics (APGE) United States $1.054B 0.00
Ligand Pharmaceuticals (LGND) United States $1.045B 23.16
Morphic Holding (MORF) United States $1.022B 0.00
Protagonist Therapeutics (PTGX) United States $1.006B 0.00
Pliant Therapeutics (PLRX) United States $0.997B 0.00
Prime Medicine (PRME) United States $0.997B 0.00
Deciphera Pharmaceuticals (DCPH) United States $0.982B 0.00
Keros Therapeutics (KROS) United States $0.953B 0.00
Replimune (REPL) United States $0.942B 0.00
Pharming Group (PHGUF) Netherlands $0.913B 0.00
ACELYRIN, INC (SLRN) United States $0.908B 0.00
MiMedx (MDXG) United States $0.903B 0.00
Pharming Group (PHAR) Netherlands $0.876B 0.00
Inhibrx (INBX) United States $0.867B 0.00
Cytek Biosciences (CTKB) United States $0.865B 0.00
Immatics (IMTX) Germany $0.856B 0.00
Belite Bio (BLTE) United States $0.851B 0.00
Kymera Therapeutics (KYMR) United States $0.849B 0.00
Cogent Biosciences (COGT) United States $0.828B 0.00
Adaptive Biotechnologies (ADPT) United States $0.804B 0.00
ADMA Biologics Inc (ADMA) United States $0.798B 0.00
Intercept Pharmaceuticals (ICPT) United States $0.782B 0.00
PureTech Health (PRTC) United States $0.778B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.756B 0.00
REGENXBIO (RGNX) United States $0.755B 0.00
Sana Biotechnology (SANA) United States $0.742B 0.00
POINT Biopharma Global (PNT) United States $0.721B 7.84
Arcturus Therapeutics Holdings (ARCT) United States $0.711B 14.07
Vera Therapeutics (VERA) United States $0.702B 0.00
Viridian Therapeutics (VRDN) United States $0.678B 0.00
Novavax (NVAX) United States $0.671B 0.00
ImmunityBio (IBRX) United States $0.671B 0.00
Ambrx Biopharma (AMAM) United States $0.657B 0.00
HilleVax (HLVX) United States $0.656B 0.00
Sinovac Biotech (SVA) China $0.644B 0.00
Travere Therapeutics (TVTX) United States $0.640B 0.00
Avid Bioservices (CDMO) United States $0.632B 0.00
Kura Oncology (KURA) United States $0.627B 0.00
Pharma Mar (PHMMF) Spain $0.621B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.598B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.593B 0.00
Cabaletta Bio (CABA) United States $0.592B 0.00
Phathom Pharmaceuticals (PHAT) United States $0.583B 0.00
Tyra Biosciences (TYRA) United States $0.579B 0.00
Editas Medicine (EDIT) United States $0.576B 0.00
Rapt Therapeutics (RAPT) United States $0.574B 0.00
Allogene Therapeutics (ALLO) United States $0.563B 0.00
Anavex Life Sciences (AVXL) United States $0.557B 0.00
Genelux (GNLX) United States $0.554B 0.00
Alector (ALEC) United States $0.539B 0.00
Olema Pharmaceuticals (OLMA) United States $0.532B 0.00
Tarsus Pharmaceuticals (TARS) United States $0.529B 0.00
Repare Therapeutics (RPTX) Canada $0.524B 0.00
WAVE Life Sciences (WVE) Singapore $0.524B 0.00
Biomea Fusion (BMEA) United States $0.499B 0.00
Entrada Therapeutics (TRDA) United States $0.494B 0.00
AnaptysBio (ANAB) United States $0.482B 0.00
Avidity Biosciences (RNA) United States $0.473B 0.00
Janux Therapeutics (JANX) United States $0.458B 0.00
23andMe Holding (ME) United States $0.455B 0.00
IGM Biosciences (IGMS) United States $0.451B 0.00
Agenus (AGEN) United States $0.437B 0.00
Caribou Biosciences (CRBU) United States $0.433B 0.00
Zymeworks (ZYME) United States $0.432B 2.28
Castle Biosciences (CSTL) United States $0.431B 0.00
Cullinan Oncology (CGEM) United States $0.428B 0.00
Mineralys Therapeutics (MLYS) United States $0.413B 0.00
Nurix Therapeutics (NRIX) United States $0.411B 0.00
Icosavax (ICVX) United States $0.410B 0.00
Liquidia Technologies (LQDA) United States $0.409B 0.00
ITeos Therapeutics (ITOS) United States $0.406B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.406B 0.00
Oculis Holding AG (OCS) Switzerland $0.402B 0.00
Nautilus Biotechnology (NAUT) United States $0.397B 0.00
Edgewise Therapeutics (EWTX) United States $0.388B 0.00
Oric Pharmaceuticals (ORIC) United States $0.384B 0.00
Scholar Rock Holding (SRRK) United States $0.382B 0.00
Coherus BioSciences (CHRS) United States $0.376B 0.00
Aerovate Therapeutics (AVTE) United States $0.362B 0.00
Urogen Pharma (URGN) United States $0.362B 0.00
Arcutis Biotherapeutics (ARQT) United States $0.359B 0.00
Precigen (PGEN) United States $0.358B 0.00
Aura Biosciences (AURA) United States $0.355B 0.00
Amarin (AMRN) Ireland $0.341B 0.00
Voyager Therapeutics (VYGR) United States $0.337B 3.38
Oxford BioMedica (OXBDF) United Kingdom $0.336B 0.00
AN2 Therapeutics (ANTX) United States $0.334B 0.00
Apollomics (APLM) Taiwan $0.331B 0.00
UniQure (QURE) Netherlands $0.331B 0.00
Bluebird Bio (BLUE) United States $0.329B 0.00
Arbutus Biopharma (ABUS) United States $0.325B 0.00
Erasca (ERAS) United States $0.320B 0.00
Monte Rosa Therapeutics (GLUE) United States $0.317B 0.00
Terns Pharmaceuticals (TERN) United States $0.313B 0.00
MaxCyte (MXCT) United States $0.313B 0.00
MeiraGTx Holdings (MGTX) United States $0.308B 0.00
Nuvation Bio (NUVB) United States $0.304B 0.00
Seres Therapeutics (MCRB) United States $0.299B 0.00
Humacyte (HUMA) United States $0.294B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.287B 0.00
Zura Bio (ZURA) United States $0.284B 0.00
Orchestra BioMed Holdings (OBIO) United States $0.282B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.280B 0.00
Inozyme Pharma (INZY) United States $0.277B 0.00
Fulcrum Therapeutics (FULC) United States $0.273B 0.00
Anika Therapeutics (ANIK) United States $0.271B 0.00
Ovid Therapeutics (OVID) United States $0.268B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.261B 16.82
ScPharmaceuticals (SCPH) United States $0.255B 0.00
Compass Therapeutics (CMPX) United States $0.254B 0.00
Atea Pharmaceuticals (AVIR) United States $0.254B 0.00
Third Harmonic Bio (THRD) United States $0.252B 0.00
AC Immune (ACIU) Switzerland $0.251B 0.00
DBV Technologies S.A (DBVT) France $0.250B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.248B 0.00
Lifecore Biomedical (LFCR) United States $0.240B 0.00
Nuvectis Pharma (NVCT) United States $0.236B 0.00
Astria Therapeutics (ATXS) United States $0.235B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.233B 0.00
Scilex Holding (SCLX) United States $0.233B 0.00
Inventiva S.A (IVA) France $0.230B 0.00
Kamada (KMDA) Israel $0.226B 17.41
Verastem (VSTM) United States $0.226B 0.00
Immuneering (IMRX) United States $0.225B 0.00
Renovaro Biosciences (RENB) United States $0.221B 0.00
Akoya Biosciences (AKYA) United States $0.218B 0.00
Vigil Neuroscience (VIGL) United States $0.218B 0.00
Gracell Biotechnologies (GRCL) China $0.214B 0.00
Celcuity (CELC) United States $0.213B 0.00
Poseida Therapeutics (PSTX) United States $0.206B 0.00
ALX Oncology Holdings (ALXO) United States $0.203B 0.00
CorMedix Inc (CRMD) United States $0.201B 0.00
Innate Pharma S.A (IPHA) France $0.200B 0.00
Mesoblast (MESO) Australia $0.200B 0.00
Fate Therapeutics (FATE) United States $0.199B 0.00
Sutro Biopharma (STRO) United States $0.199B 0.00
Sagimet Biosciences (SGMT) United States $0.195B 0.00
TELA Bio (TELA) United States $0.195B 0.00
Tenaya Therapeutics (TNYA) United States $0.195B 0.00
Praxis Precision Medicines (PRAX) United States $0.190B 0.00
Allakos (ALLK) United States $0.188B 0.00
Rallybio (RLYB) United States $0.187B 0.00
Ikena Oncology (IKNA) United States $0.187B 0.00
Invivyd (IVVD) United States $0.180B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.177B 0.00
Gossamer Bio (GOSS) United States $0.177B 0.00
X4 Pharmaceuticals (XFOR) United States $0.174B 0.00
2seventy Bio (TSVT) United States $0.174B 0.00
Adverum Biotechnologies (ADVM) United States $0.174B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.174B 0.00
Stoke Therapeutics (STOK) United States $0.172B 0.00
Prima BioMed (IMMP) Australia $0.171B 0.00
Vaxxinity (VAXX) United States $0.171B 0.00
Selecta Biosciences (SELB) United States $0.170B 0.00
Emergent Biosolutions (EBS) United States $0.169B 0.00
MEREO BIOPHARMA (MREO) United Kingdom $0.166B 0.00
XOMA (XOMA) United States $0.163B 0.00
GENFIT S.A (GNFT) France $0.163B 0.00
Molecular Partners AG (MOLN) Switzerland $0.163B 0.00
Oncolytics Biotech (ONCY) Canada $0.161B 0.00
PDS Biotechnology (PDSB) United States $0.161B 0.00
LianBio (LIAN) United States $0.161B 0.00
Atara Biotherapeutics (ATRA) United States $0.159B 0.00
Applied Therapeutics (APLT) United States $0.155B 0.00
Mersana Therapeutics (MRSN) United States $0.151B 0.00
Rani Therapeutics Holdings (RANI) United States $0.146B 0.00
Vor Biopharma (VOR) $0.145B 0.00
Graphite Bio (GRPH) United States $0.144B 0.00
Mind Medicine (MindMed) (MNMD) United States $0.144B 0.00
Seer (SEER) United States $0.143B 0.00
Ocean Biomedical (OCEA) United States $0.142B 0.00
Trevi Therapeutics (TRVI) United States $0.139B 0.00
Design Therapeutics (DSGN) United States $0.135B 0.00
Adocia (ADOCY) France $0.135B 0.00
Annexon (ANNX) United States $0.130B 0.00
InflaRx (IFRX) Germany $0.130B 0.00
Puma Biotechnology (PBYI) United States $0.129B 0.00
TScan Therapeutics (TCRX) United States $0.129B 0.00
Longboard Pharmaceuticals (LBPH) United States $0.129B 0.00
Aadi Bioscience (AADI) United States $0.128B 0.00
Omega Therapeutics (OMGA) United States $0.127B 0.00
XBiotech (XBIT) United States $0.127B 0.00
INmune Bio (INMB) United States $0.126B 0.00
Sangamo Therapeutics (SGMO) United States $0.120B 0.00
PepGen (PEPG) United States $0.120B 0.00
Absci (ABSI) United States $0.119B 0.00
Theseus Pharmaceuticals (THRX) United States $0.119B 0.00
Eton Pharmaceuticals (ETON) United States $0.119B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.117B 0.00
Gritstone Bio (GRTS) United States $0.112B 0.00
Greenwich LifeSciences (GLSI) United States $0.110B 0.00
ChromaDex (CDXC) United States $0.107B 0.00
Kodiak Sciences (KOD) United States $0.107B 0.00
Vaccitech (VACC) United Kingdom $0.106B 0.00
Cue Biopharma (CUE) United States $0.106B 0.00
Codexis (CDXS) United States $0.105B 0.00
Ocugen (OCGN) United States $0.104B 0.00
MediciNova (MNOV) United States $0.103B 0.00
I-Mab (IMAB) China $0.102B 0.00
Gamida Cell (GMDA) United States $0.102B 0.00
Opthea (OPT) Australia $0.102B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.101B 0.00
Inovio Pharmaceuticals (INO) United States $0.101B 0.00
Bionano Genomics (BNGO) United States $0.100B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.100B 0.00
Abeona Therapeutics (ABEO) United States $0.100B 0.00
DiaMedica Therapeutics (DMAC) United States $0.099B 0.00
PhenomeX (CELL) United States $0.099B 0.00
Genenta Science S.p.A (GNTA) Italy $0.098B 0.00
Cara Therapeutics (CARA) United States $0.097B 0.00
C4 Therapeutics (CCCC) United States $0.092B 0.00
Spruce Biosciences (SPRB) United States $0.092B 0.00
ATyr Pharma (LIFE) United States $0.091B 0.00
Cellectis S.A (CLLS) France $0.090B 0.00
Immunome (IMNM) United States $0.090B 0.00
BRIACELL THERAP (BCTX) Canada $0.089B 0.00
Cidara Therapeutics (CDTX) United States $0.088B 0.00
NGM Biopharmaceuticals (NGM) United States $0.087B 0.00
Annovis Bio (ANVS) United States $0.086B 0.00
IO Biotech (IOBT) Denmark $0.085B 0.00
Data Knights Acquisition (DKDCA) United Kingdom $0.085B 0.00
Ocuphire Pharma (OCUP) United States $0.084B 4.79
CytomX Therapeutics (CTMX) United States $0.084B 0.00
BioAtla (BCAB) United States $0.084B 0.00
Compugen (CGEN) Israel $0.083B 0.00
Alpha Teknova (TKNO) United States $0.083B 0.00
Nkarta (NKTX) United States $0.082B 0.00
Turnstone Biologics (TSBX) United States $0.081B 0.00
Syros Pharmaceuticals (SYRS) United States $0.081B 0.00
BioXcel Therapeutics (BTAI) United States $0.081B 0.00
Beyond Air (XAIR) United States $0.080B 0.00
Graf Acquisition IV (GFOR) United States $0.079B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.079B 0.00
Kezar Life Sciences (KZR) United States $0.079B 0.00
Evelo Biosciences (EVLO) United States $0.076B 0.00
Jasper Therapeutics (JSPR) United States $0.075B 0.00
Athira Pharma (ATHA) United States $0.075B 0.00
Elicio Therapeutics (ELTX) United States $0.074B 0.00
HCW Biologics (HCWB) United States $0.074B 0.00
Kronos Bio (KRON) United States $0.073B 0.00
Cardiff Oncology (CRDF) United States $0.072B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.072B 0.00
Werewolf Therapeutics (HOWL) United States $0.071B 0.00
Genetron Holdings (GTH) China $0.071B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.070B 0.00
AVROBIO (AVRO) United States $0.069B 0.00
Affimed (AFMD) Germany $0.069B 0.00
Enzo Biochem (ENZ) United States $0.069B 0.00
Tiziana Life Sciences (TLSA) United Kingdom $0.068B 0.00
Clene (CLNN) United States $0.067B 0.00
G1 Therapeutics (GTHX) United States $0.065B 0.00
Kinnate Biopharma (KNTE) United States $0.065B 0.00
Immix Biopharma (IMMX) United States $0.064B 0.00
Spero Therapeutics (SPRO) United States $0.064B 0.00
Shattuck Labs (STTK) United States $0.064B 0.00
Eyenovia (EYEN) United States $0.063B 0.00
Prenetics Global (PRE) Cayman Islands $0.062B 1.45
Adicet Bio (ACET) United States $0.062B 0.00
Xilio Therapeutics (XLO) United States $0.061B 0.00
Adagene (ADAG) China $0.060B 0.00
Immunic (IMUX) United States $0.060B 0.00
Oncobiologics (OTLK) United States $0.057B 0.00
Sorrento Therapeutics (SRNEQ) United States $0.056B 0.00
Dyadic (DYAI) United States $0.055B 0.00
Instil Bio (TIL) United States $0.053B 0.00
Clearside Biomedical (CLSD) United States $0.053B 0.00
Intensity Therapeutics (INTS) United States $0.053B 0.00
Solid Biosciences (SLDB) United States $0.052B 0.00
VistaGen Therapeutics (VTGN) United States $0.050B 0.00
Dianthus Therapeutics (DNTH) United States $0.050B 0.00
HOOKIPA Pharma (HOOK) United States $0.050B 0.00
Curis (CRIS) United States $0.050B 0.00
Rezolute (RZLT) United States $0.050B 0.00
Galena Biopharma (SLS) United States $0.048B 0.00
OKYO Pharma (OKYO) $0.048B 0.00
VTv Therapeutics (VTVT) United States $0.047B 0.00
Longeveron (LGVN) United States $0.047B 0.00
Science 37 Holdings (SNCE) United States $0.047B 0.00
Celularity (CELU) United States $0.046B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.046B 0.00
MiNK Therapeutics (INKT) United States $0.043B 0.00
Precision BioSciences (DTIL) United States $0.043B 0.00
Quince Therapeutics (QNCX) United States $0.043B 0.00
Theratechnologies (THTX) Canada $0.042B 0.00
Dare Bioscience (DARE) United States $0.041B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.040B 0.00
Connect Biopharma Holdings (CNTB) United States $0.040B 0.00
Coya Therapeutics (COYA) United States $0.040B 0.00
Portage Biotech (PRTG) $0.040B 0.00
Lantern Pharma (LTRN) United States $0.039B 0.00
Cognition Therapeutics (CGTX) United States $0.039B 0.00
Mainz Biomed (MYNZ) Germany $0.038B 0.00
Fortress Biotech (FBIO) United States $0.038B 0.00
Passage Bio (PASG) United States $0.037B 0.00
NextCure (NXTC) United States $0.037B 0.00
Bolt Biotherapeutics (BOLT) United States $0.037B 0.00
IN8bio (INAB) United States $0.036B 0.00
Miromatrix Medical (MIRO) United States $0.036B 0.00
Achilles Therapeutics (ACHL) United Kingdom $0.036B 0.00
Leap Therapeutics (LPTX) United States $0.035B 0.00
UNITY Biotechnology (UBX) United States $0.035B 0.00
Neoleukin Therapeutics (NLTX) United States $0.034B 0.00
Telesis Bio (TBIO) United States $0.034B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.032B 0.00
Aligos Therapeutics (ALGS) United States $0.032B 0.00
Rain Oncology (RAIN) United States $0.031B 0.00
Biora Therapeutics (BIOR) United States $0.031B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.030B 0.00
NuCana (NCNA) United Kingdom $0.030B 0.00
BeyondSpring (BYSI) United States $0.030B 0.00
Checkpoint Therapeutics (CKPT) United States $0.030B 0.00
Eledon Pharmaceuticals (ELDN) United States $0.029B 0.00
Elevation Oncology (ELEV) United States $0.029B 0.00
Candel Therapeutics (CADL) United States $0.029B 0.00
Alimera Sciences (ALIM) United States $0.028B 0.00
Cyclo Therapeutics (CYTH) United States $0.028B 0.00
SAB Biotherapeutics (SABS) United States $0.027B 0.00
Liminal BioSciences (LMNL) Canada $0.026B 0.00
TradeUP Acquisition (UPTD) United States $0.026B 0.00
Evogene (EVGN) Israel $0.025B 0.00
Forte Biosciences (FBRX) United States $0.025B 0.00
Equillium (EQ) United States $0.025B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.024B 0.00
KALA BIO (KALA) United States $0.024B 0.00
Kineta (KA) United States $0.024B 0.00
Pluri (PLUR) Israel $0.024B 0.00
GENPREX (GNPX) United States $0.024B 0.00
Axcella Health (AXLA) United States $0.023B 0.00
Sensei Biotherapeutics (SNSE) United States $0.023B 0.00
Seelos Therapeutics (SEEL) United States $0.023B 0.00
Synlogic (SYBX) United States $0.023B 0.00
Femasys (FEMY) United States $0.022B 0.00
Lumos Pharma (LUMO) United States $0.022B 0.00
EFFECTOR Therapeutics (EFTR) United States $0.022B 0.00
Evaxion Biotech (EVAX) Denmark $0.022B 0.00
Cocrystal Pharma (COCP) United States $0.022B 0.00
Aptose Biosciences (APTO) Canada $0.021B 0.00
Senti Biosciences (SNTI) United States $0.021B 0.00
YS Biopharma (YS) China $0.021B 1.04
Medicenna Therapeutics (MDNA) Canada $0.021B 0.00
Elutia (ELUT) United States $0.020B 0.00
Entera Bio (ENTX) Israel $0.020B 0.00
Vincerx Pharma (VINC) United States $0.020B 0.00
Acurx Pharmaceuticals (ACXP) United States $0.020B 0.00
Purple Biotech (PPBT) Israel $0.019B 0.00
Catalyst Biosciences (CBIO) United States $0.019B 0.00
Acorda Therapeutics (ACOR) United States $0.019B 0.00
Mustang Bio (MBIO) United States $0.019B 0.00
Alzamend Neuro (ALZN) United States $0.019B 0.00
Hepion Pharmaceuticals (HEPA) United States $0.019B 0.00
Virios Therapeutics (VIRI) United States $0.018B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.018B 0.00
Edesa Biotech (EDSA) Canada $0.017B 0.00
Orgenesis (ORGS) United States $0.017B 0.00
AquaBounty Technologies (AQB) United States $0.017B 0.00
Freeline Therapeutics Holdings (FRLN) United Kingdom $0.017B 0.00
Lisata Therapeutics (LSTA) United States $0.017B 0.00
Promis Neurosciences (PMN) Canada $0.017B 0.00
Vascular Biogenics (VBLT) Israel $0.017B 0.00
Novogen (KZIA) Australia $0.016B 0.00
Genetic Technologies (GENE) Australia $0.016B 0.00
PHAXIAM Therapeutics S.A (PHXM) France $0.016B 0.00
Aprea Therapeutics (APRE) United States $0.016B 0.00
Galecto (GLTO) Denmark $0.015B 0.00
CalciMedica (CALC) United States $0.015B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.015B 0.00
Eiger BioPharmaceuticals (EIGR) United States $0.015B 0.00
RenovoRx (RNXT) United States $0.015B 0.00
VBI Vaccines (VBIV) United States $0.014B 0.00
Frequency Therapeutics (FREQ) United States $0.014B 0.00
Senesco Technologies (ELOX) United States $0.014B 0.00
GeoVax Labs (GOVX) United States $0.014B 0.00
NeuroBo Pharmaceuticals (NRBO) United States $0.013B 0.00
Moleculin Biotech (MBRX) United States $0.013B 0.00
Biofrontera (BFRI) United States $0.012B 0.00
ZIVO Bioscience (ZIVO) United States $0.012B 0.00
Pasithea Therapeutics (KTTA) United States $0.012B 0.00
TFF Pharmaceuticals (TFFP) United States $0.012B 0.00
AEterna Zentaris (AEZS) Canada $0.012B 0.00
Landos Biopharma (LABP) United States $0.012B 0.00
Organovo Holdings (ONVO) United States $0.012B 0.00
IMMURON (IMRN) Australia $0.011B 0.00
Eterna Therapeutics (ERNA) United States $0.011B 0.00
Cingulate (CING) United States $0.011B 0.00
Talis Biomedical (TLIS) United States $0.011B 0.00
Comera Life Sciences Holdings (CMRA) United States $0.011B 0.00
Prana Biotechnology (ATHE) Australia $0.011B 0.00
GT Biopharma (GTBP) United States $0.010B 0.00
Chemomab Therapeutics (CMMB) Israel $0.010B 0.00
Atreca (BCEL) United States $0.010B 0.00
BioAffinity Technologies (BIAF) United States $0.010B 0.00
Avalon GloboCare (ALBT) United States $0.010B 0.00
ARAVIVE, INC (ARAV) United States $0.010B 0.00
Imunon (IMNN) United States $0.010B 0.00
Lipella Pharmaceuticals (LIPO) United States $0.010B 0.00
Blue Water Biotech (BWV) United States $0.009B 0.00
Virpax Pharmaceuticals (VRPX) United States $0.009B 0.00
BioCardia (BCDA) United States $0.009B 0.00
Cyclerion Therapeutics (CYCN) United States $0.009B 0.00
Trevena (TRVN) United States $0.009B 0.00
Cadrenal Therapeutics (CVKD) United States $0.009B 0.00
Cohbar (CWBR) United States $0.008B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.008B 0.00
Monopar Therapeutics (MNPR) United States $0.008B 0.00
Galera Therapeutics (GRTX) United States $0.008B 0.00
Sunshine Biopharma (SBFM) Canada $0.008B 0.00
Atrinsic (PTIX) United States $0.008B 0.00
Bionomics (BNOX) Australia $0.008B 0.00
Lexaria Bioscience (LEXX) Canada $0.008B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.008B 0.00
Titan Pharmaceuticals (TTNP) United States $0.008B 0.00
Athersys (ATHX) United States $0.007B 0.00
Pulmatrix (PULM) United States $0.007B 0.00
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.007B 0.00
Biorestorative Therapies (BRTX) United States $0.007B 0.00
Kintara Therapeutics (KTRA) United States $0.007B 0.00
Tenax Therapeutics (TENX) United States $0.007B 0.00
Applied Molecular Transport (AMTI) United States $0.007B 0.00
Biophytis SA (BPTS) France $0.007B 0.00
Aileron Therapeutics (ALRN) United States $0.007B 0.00
Exicure (XCUR) United States $0.007B 0.46
CervoMed (CRVO) United States $0.006B 0.00
Aytu BioPharma (AYTU) United States $0.006B 0.00
Bright Minds Biosciences (DRUG) United States $0.006B 0.00
TRACON Pharmaceuticals (TCON) United States $0.006B 0.00
Silo Pharma (SILO) United States $0.006B 0.00
Vaccinex (VCNX) United States $0.006B 0.00
NexImmune (NEXI) United States $0.005B 0.00
PaxMedica (PXMD) United States $0.005B 0.00
Benitec Biopharma (BNTC) United States $0.005B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.005B 0.00
Hoth Therapeutics (HOTH) United States $0.005B 0.00
Virax Biolabs Group (VRAX) United Kingdom $0.005B 0.00
GRI Bio (GRI) United States $0.005B 0.00
Bellerophon Therapeutics (BLPH) United States $0.005B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.005B 0.00
Enveric Biosciences (ENVB) United States $0.005B 0.00
Windtree Therapeutics (WINT) United States $0.005B 0.00
CNS Pharmaceuticals (CNSP) United States $0.005B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.004B 0.00
Artelo Biosciences (ARTL) United States $0.004B 0.00
Soligenix (SNGX) United States $0.004B 0.00
Revelation Biosciences (REVB) United States $0.004B 0.00
Ensysce Biosciences (ENSC) United States $0.004B 0.00
ZyVersa Therapeutics (ZVSA) United States $0.004B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.004B 0.00
Synaptogenix (SNPX) United States $0.004B 0.00
Adial Pharmaceuticals (ADIL) United States $0.004B 0.00
Panbela Therapeutics (PBLA) United States $0.004B 0.00
ABVC BioPharma (ABVC) United States $0.004B 0.00
Palisade Bio (PALI) United States $0.004B 0.04
Aptevo Therapeutics (APVO) United States $0.004B 0.00
Dermata Therapeutics (DRMA) United States $0.003B 0.00
ThermoGenesis Holdings (THMO) United States $0.003B 0.00
Aceragen (ACGN) United States $0.003B 0.00
180 Life Sciences (ATNF) United States $0.003B 0.25
Bone Biologics (BBLG) United States $0.002B 0.00
First Wave BioPharma (FWBI) United States $0.002B 0.06
Invo BioScience (INVO) United States $0.002B 0.00
Allarity Therapeutics (ALLR) United States $0.002B 0.00
NeuBase Therapeutics (NBSE) United States $0.002B 0.00
Scinai Immunotherapeutics (SCNI) Israel $0.002B 0.00
TC BioPharm (Holdings) (TCBP) United Kingdom $0.000B 0.00
MorphoSys AG (MOR) Germany $0.000B 16.88
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $0.000B 0.00
ARCA Biopharma (ABIO) United States $0.000B 0.00
Alvotech (ALVO) $0.000B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
GH Research (GHRS) Ireland $0.000B 0.00
LAVA Therapeutics (LVTX) Netherlands $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
Pharvaris (PHVS) Netherlands $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00